Global Injectable Ketamine Market Growth 2026-2032
Description
The global Injectable Ketamine market size is predicted to grow from US$ 842 million in 2025 to US$ 2480 million in 2032; it is expected to grow at a CAGR of 17.0% from 2026 to 2032.
Injectable ketamine is a form of the anesthetic drug ketamine that is administered via injection, typically intravenously (IV) or intramuscularly (IM). Ketamine is a dissociative anesthetic, meaning it causes a sense of detachment from the body and environment. It was originally developed in the 1960s as an anesthetic for surgical procedures but has since found various uses in both medical and psychiatric settings.
United States market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Injectable Ketamine players cover Greenco Biologicals, Pfizer, BNM Organics, Seqens, Troikaa Parenterals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Injectable Ketamine Industry Forecast” looks at past sales and reviews total world Injectable Ketamine sales in 2025, providing a comprehensive analysis by region and market sector of projected Injectable Ketamine sales for 2026 through 2032. With Injectable Ketamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Ketamine industry.
This Insight Report provides a comprehensive analysis of the global Injectable Ketamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Ketamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Ketamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Ketamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Ketamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Ketamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Low-Dose Ketamine
Standard Ketamine
High-Dose Ketamine
Segmentation by Application:
Anesthetic Use
Pain Management
Mental Health Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Greenco Biologicals
Pfizer
BNM Organics
Seqens
Troikaa Parenterals
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Ketalar
Hameln Pharma ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Injectable Ketamine market?
What factors are driving Injectable Ketamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable Ketamine market opportunities vary by end market size?
How does Injectable Ketamine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Injectable ketamine is a form of the anesthetic drug ketamine that is administered via injection, typically intravenously (IV) or intramuscularly (IM). Ketamine is a dissociative anesthetic, meaning it causes a sense of detachment from the body and environment. It was originally developed in the 1960s as an anesthetic for surgical procedures but has since found various uses in both medical and psychiatric settings.
United States market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Injectable Ketamine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Injectable Ketamine players cover Greenco Biologicals, Pfizer, BNM Organics, Seqens, Troikaa Parenterals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Injectable Ketamine Industry Forecast” looks at past sales and reviews total world Injectable Ketamine sales in 2025, providing a comprehensive analysis by region and market sector of projected Injectable Ketamine sales for 2026 through 2032. With Injectable Ketamine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Injectable Ketamine industry.
This Insight Report provides a comprehensive analysis of the global Injectable Ketamine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Injectable Ketamine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Injectable Ketamine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Injectable Ketamine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Injectable Ketamine.
This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Ketamine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Low-Dose Ketamine
Standard Ketamine
High-Dose Ketamine
Segmentation by Application:
Anesthetic Use
Pain Management
Mental Health Treatment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Greenco Biologicals
Pfizer
BNM Organics
Seqens
Troikaa Parenterals
Neon Laboratories
Samarth Pharma
Sun Pharmaceuticals
Supriya Lifesciences
Taj Pharmaceuticals
Hengrui
Anhui Wanhe Pharmaceutical
Ketalar
Hameln Pharma ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Injectable Ketamine market?
What factors are driving Injectable Ketamine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Injectable Ketamine market opportunities vary by end market size?
How does Injectable Ketamine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
114 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Injectable Ketamine by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Injectable Ketamine by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
